Yes sey
The choice between racemates and single enantiomers depends on therapeutic advances and developmental costs. There is undoubtedly a need for critical evaluation of existing racemic drugs.
The choice between racemates and single enantiomers depends on therapeutic advances and developmental costs. There is undoubtedly a need for critical evaluation of existing racemic drugs.
ReplyDelete